Technical Analysis for HBIO - Harvard Bioscience, Inc.

Grade Last Price % Change Price Change
grade F 2.36 -0.42% -0.01
HBIO closed down 0.42 percent on Friday, May 17, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical HBIO trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -0.42%
NR7 Range Contraction -0.42%
Inside Day Range Contraction -0.42%
Wide Bands Range Expansion -0.42%
Oversold Stochastic Weakness -0.42%
New 52 Week Low Weakness 2.16%

Older signals for HBIO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Chemistry Biotechnology Physical Sciences Natural Sciences Molecular Biology Neuroscience Dialysis Cell Biology Agilent Technologies Regenerative Medicine Proteomics Gel Electrophoresis
Is HBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.7
52 Week Low 2.26
Average Volume 163,255
200-Day Moving Average 4.1764
50-Day Moving Average 3.6959
20-Day Moving Average 3.148
10-Day Moving Average 2.52
Average True Range 0.2096
ADX 44.29
+DI 7.9751
-DI 38.7784
Chandelier Exit (Long, 3 ATRs ) 3.8112
Chandelier Exit (Short, 3 ATRs ) 2.8888
Upper Bollinger Band 4.5087
Lower Bollinger Band 1.7873
Percent B (%b) 0.21
BandWidth 86.448539
MACD Line -0.4574
MACD Signal Line -0.3782
MACD Histogram -0.0792
Fundamentals Value
Market Cap 82.21 Million
Num Shares 34.8 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -18.15
Price-to-Sales 1.19
Price-to-Book 1.60
PEG Ratio 2.65
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.50
Resistance 3 (R3) 2.50 2.47 2.47
Resistance 2 (R2) 2.47 2.43 2.46 2.46
Resistance 1 (R1) 2.41 2.41 2.44 2.41 2.46
Pivot Point 2.38 2.38 2.39 2.37 2.38
Support 1 (S1) 2.32 2.34 2.35 2.32 2.26
Support 2 (S2) 2.29 2.32 2.28 2.26
Support 3 (S3) 2.23 2.29 2.25
Support 4 (S4) 2.23